Egyptian healthtech Almouneer raises $3.6m seed to scale

Key Takeaways

The Middle East and Africa (MEA) region grapples with alarmingly high rates of obesity and prediabetes, affecting more than 40% of its population. This underscores the crucial mission of Almouneer and its platform DRU, which aims to empower both patients and healthcare professionals in addressing this pressing health issue. In Egypt alone, there are 15 million individuals diagnosed with diabetes, representing 20% of the adult population. At the same time, the Kingdom of Saudi Arabia (KSA) has 7 million diabetes cases, equivalent to 30% of its adult population. When considering those dealing with prediabetes and obesity, the problem becomes even more widespread, although it is largely preventable through lifestyle management and monitoring. This capital raise is particularly timely, following significant growth for Almouneer. The startup, headquartered in Giza, currently serves more than 120,000 patients through a network of nine hospitals and clinics in Egypt. Notably, the healthtech company has reported a doubling of its business volumes and revenue figures in the past year, underscoring its impactful contribution to healthcare in the region.